Funder
Jiangsu Science and Technology Department
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference13 articles.
1. DeAngelo DJ, Yu D, Johnson JL (2007) Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: cancer and leukemia group B study 19801. Blood 109:5136–5142
2. Cohen MH, Johnson JR, Justice R, Pazdur R (2008) FDA drug approval summary: nelarabine (arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Oncologist 13(6):709–714
3. Roecker AM, Stockert A, Kisor DF (2010) Nelarabine in the Treatment of refractory T-Cell malignancies. Clin Med Insights Oncol 4:133–141
4. Gandhi V, Keating MJ, Bate G, Kirkpatrick P (2006) Nelarabine. Nat Rev Drug Discov 5:17–18
5. Cooper TM (2007) Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Ther Clin Risk Manag 3:1135
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献